We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

On Wednesday, TScan Therapeutics, Inc. (NASDAQ: TCRX) received positive remarks from TD Cowen following an update on its clinical ...

Morgan Stanley reaffirmed their overweight rating on shares of TScan Therapeutics (NASDAQ:TCRX – Free Report) in a research note published on Friday morning,Benzinga reports. They currently have ...

3/5/2025 – TScan Therapeutics had its price target lowered by analysts at Needham & Company LLC from $11.00 to $9.00. They now have a “buy” rating on the stock.

TScan Therapeutics Inc. (NASDAQ:TCRX), a biotechnology company specializing in T-cell receptor (TCR) therapies with a market capitalization of $102 million, is navigating a critical phase in its ...

Channel 5 has rebranded to ‘5’ across its linear, streaming and digital platforms in a move aimed at strengthening perceptions of its content quality and range. The change, effective today (12 March), ...

“This isn't just a retro pastiche. The 5 is almost as joyful to use as it is to look at. Strong value cements the appeal” The cold rational left-brain summary is simple. The Renault 5 is an ...